Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06654063 | RECRUITING | Vitamin D Deficiency

Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis Patients
Sponsor:

Cairo University

Information provided by (Responsible Party):

Marwa Halll

Brief Summary:

Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D daily Supplements on Active Periodontal Therapy with Stage II Grade B Periodontitis Patients: A Randomized controlled clinical trial.

Condition or disease

Vitamin D Deficiency

Intervention/treatment

non-surgical periodontal therapy (SRP)

non-surgical periodontal therapy (SRP)+ Omega-3

non-surgical periodontal therapy (SRP)+ Vitamin D

Phase

NA

Detailed Description:

This randomized clinical trial evaluates the effect of Omega- 3 versus Vitamin D regarding Clinical evaluation 1. Clinical attachment loss (CAL) 2. Probing pocket depth (PPD) 3. Modified sulcus bleeding index (mSBI)

Study Type : INTERVENTIONAL
Estimated Enrollment : 72 participants
Masking : DOUBLE
Primary Purpose : TREATMENT
Official Title : Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis Patients: A Randomized Controlled Clinical Trial.
Actual Study Start Date : 2025-06-01
Estimated Primary Completion Date : 2025-06-15
Estimated Study Completion Date : 2025-06-15

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 25 Years to 50 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * • Systemic healthy patients
  • * Patients aged \> 25 years
  • * Patients suffering from stage II periodontitis with grade B were included in this study, according to 2017 world workshop classification of periodontal disease (Papapanou et al. 2017).
  • * Patients with interdental clinical attachment loss (CAL) of 3-4 mm
  • * No history of previous periodontal therapy.
  • * No taken medications known to interfere healing or periodontal tissue health such as anticonvulsants, calcium channel blockers, or immunosuppressant drugs.
  • * No previous periodontal surgery at involved sites.
  • * Good oral hygiene and good compliance with the plaque control instructions following initial therapy.
  • * Neither taken antibiotics within the last three months nor nonsteroidal anti-inflammatory drugs within the last three months
  • * Absence of diseases or conditions that would interfere with wound healing such as diabetes mellitus or coagulation disorders
  • * Absence of oral mucosal inflammatory conditions such as aphthous ulcers or lichen planus.
Exclusion Criteria
  • * • Patients taking Omega- 3 or Vitamin D as a nutritional supplement were excluded from the study
  • * Smoking habits
  • * Pregnant and lactating mothers
  • * Patients who have been received periodontal surgery in the study area during the last 6 months.
Clinical Assessment of Adjunctive Omega-3 Versus Vitamin D Daily Supplements on Active Periodontal Therapy With Stage II Grade B Periodontitis Patients

Location Details

NCT06654063

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

Egypt,

Marwa Halll

Cairo, Egypt, 02